These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27552516)

  • 21. A video study of drop instillation in both glaucoma and retina patients with visual impairment.
    Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
    Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success.
    Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW
    J Glaucoma; 2019 Mar; 28(3):e46-e48. PubMed ID: 30822299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for quantifying difficulty in squeezing eyedrops from their containers.
    Nesher R; Ezra-Nimni O; Shumla E; Gur J; Hamisha S; Nesher G
    Arch Ophthalmol; 2007 Aug; 125(8):1114-7. PubMed ID: 17698760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic glaucoma drop bottle cap colours.
    Hallaji NAE; Trope GE
    Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey.
    Moore DB; Walton C; Moeller KL; Slabaugh MA; Mudumbai RC; Chen PP
    BMC Ophthalmol; 2014 Jun; 14():79. PubMed ID: 24927769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy.
    Marando CM; Seibold LK; SooHoo JR; Pantcheva MB; Ramulu PY; Kahook MY
    Ophthalmology; 2015 Dec; 122(12):2577-8. PubMed ID: 26077575
    [No Abstract]   [Full Text] [Related]  

  • 28. Usability of prostaglandin monotherapy eye droppers.
    Drew T; Wolffsohn JS
    Br J Ophthalmol; 2015 Sep; 99(9):1251-4. PubMed ID: 25761745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications.
    Schwartz GF; Platt R
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S278-80. PubMed ID: 12188171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
    Gatwood JD; Johnson J; Jerkins B
    J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter study of compliance and drop administration in glaucoma.
    Kholdebarin R; Campbell RJ; Jin YP; Buys YM
    Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eye drop instillation technique in patients with glaucoma.
    Tatham AJ; Sarodia U; Gatrad F; Awan A
    Eye (Lond); 2013 Nov; 27(11):1293-8. PubMed ID: 23970024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drop size of commercial glaucoma medications.
    Lederer CM; Harold RE
    Am J Ophthalmol; 1986 Jun; 101(6):691-4. PubMed ID: 3717253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique.
    Sayner R; Carpenter DM; Robin AL; Blalock SJ; Muir KW; Vitko M; Hartnett ME; Lawrence SD; Giangiacomo AL; Tudor G; Goldsmith JA; Sleath B
    Int J Pharm Pract; 2016 Apr; 24(2):78-85. PubMed ID: 26303667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?
    German EJ; Hurst MA; Wood D
    Eye (Lond); 1999; 13 ( Pt 1)():93-100. PubMed ID: 10396391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.
    Dasgupta S; Oates V; Bookhart BK; Vaziri B; Schwartz GF; Mozaffari E
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S255-61. PubMed ID: 12188168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic steroids.
    Gill MS; Murphy DA; Dvorak JD; Shah SV; Riaz KM
    J Cataract Refract Surg; 2022 Apr; 48(4):475-480. PubMed ID: 34653089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic nonsteroidal anti-inflammatory drugs.
    Heath M; McDonald MC; Murphy DA; Shah SV; Shah S; Ding K; Riaz KM
    J Cataract Refract Surg; 2023 Jul; 49(7):747-753. PubMed ID: 36853852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.